All rabbits were anesthetized and injected with BrdU (Sigma, St. Louis, MO) in phosphate-buffered saline (PBS; 30.3 mg/mL). BrdU is incorporated in nuclear DNA as a substitute for thymidine during the S-phase of DNA replication. The injection was performed in the lateral ear vein with a 23-gauge needle between 9:00 and 9:15 AM, to control for circadian effects. Exactly 24 hours later, rabbits were fitted unilaterally with either a low-O2 RGP lens (Dk/t = 10; n = 7, study I) or medium-O2 RGP lens (Dk/t = 27; n = 21, study II), and the other eye served as the control. The contact lens–wearing eye was randomly chosen by coin toss. Four days (n = 7, low-Dk/t RGP lens) and 2, 4, or 6 days after BrdU injection (n = 21, medium-Dk/t RGP lens), rabbits were euthanatized with an overdose of pentobarbital (0.4 mL/kg body weight; Abbott Laboratories, North Chicago, IL). In addition, a control group (n = 4) was included with no contact lens in either eye to control for possible sympathetic effects in the non–lens-wearing eye caused by the contact lens in the contralateral eye. These control rabbits were killed 4 days after injection of BrdU.